IIM
SUPN icon

INTECH Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

INTECH Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
25,973
-13,011
-33% -$625K 0.01% 943
2026
Q1 		$2.02M Sell
38,984
-22,547
-37% -$1.15M 0.02% 700
2025
Q4 		$3.06M Buy
61,531
+25,828
+72% +$1.26M 0.03% 549
2025
Q3 		$1.71M Sell
35,703
-7,401
-17% -$298K 0.02% 865
2025
Q2 		$1.36M Buy
43,104
+7,276
+20% +$233K 0.01% 1019
2025
Q1 		$1.17M Buy
35,828
+7,476
+26% +$265K 0.01% 1094
2024
Q4 		$1.03M Buy
28,352
+15,191
+115% +$535K 0.01% 1120
2024
Q3 		$410K Buy
13,161
+1,838
+16% +$57.4K ﹤0.01% 1335
2024
Q2 		$303K Buy
+11,323
New +$328K ﹤0.01% 955

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

INTECH Investment Management's SUPN Position: Q2 2026 in Review

INTECH Investment Management reduced its Supernus Pharmaceuticals (SUPN) stake by 33% in Q2 2026, selling an estimated $625K and leaving 25,973 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #943.

INTECH Investment Management first reported a position in SUPN in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.06M in Q4 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • INTECH Investment Management held 25,973 shares of Supernus Pharmaceuticals worth $1.21M as of Q2 2026.
  • INTECH Investment Management sold 13,011 Supernus Pharmaceuticals shares in Q2 2026, an estimated $625K.
  • Supernus Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #943 holding.
  • INTECH Investment Management first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • INTECH Investment Management's Supernus Pharmaceuticals position peaked at $3.06M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.